The Global Market for Biomarkers, 2015-2020 (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)

    Published: December 10, 2015 | Price: $1,396.50 – $2,793.00

    The Global Market for Biomarkers (Cancer Biomarkers, Cardiovascular Disease Biomarkers, Immunological Disease Biomarkers, Infectious Disease Biomarkers, Neurological Disease Biomarkers, Novel Biomarkers for Other Diseases) The Global Market for Biomarkers analyzes the current and future markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers: The Market for Cancer Biomarkers The Market for Cardiovascular Disease Biomarkers The Market for Immunological Disease Biomarkers The Market for Infectious Disease Biomarkers The Market for Neurological Disease Biomarkers The...
    OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition

    Published: August 1, 2003 | Price: $1,496.00 – $2,992.00

    The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others. In response to many inquiries from readers of Kalorama Information’s March 2003 publication Women’s Health: Worldwide Prescription Drug Markets, 3rd Edition, we embarked on a supplemental study that goes beyond the prescription market to...
    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    Published: October 1, 2003 | Price: $1,496.00 – $2,992.00

    Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the scientific and technical challenges of detecting prion proteins. Growth of prion testing will depend on these technology breakthroughs and the future prevalence of prion disease....
    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    Published: December 1, 2003 | Price: $1,496.00 – $2,992.00

    Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...
    Market for Generic Biologics: Issues, Trends, and Market Potential, The

    Published: June 1, 2004 | Price: $1,500.00 – $3,000.00

    Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be no generic form of biologics. That is, the complex process of creating biologics, means that traditional definitions of bioequivalence used in the generic drug industry do not (or may not)...
    Psoriasis and Psoriatic Arthritis – A Strategic Analysis of the Market in the United States

    Published: September 1, 2006 | Price: $1,500.00 – $7,000.00

    This report focuses on the applications of current and advanced therapeutics to the treatment of psoriasis and psoriatic arthritis, the options they present, and the progress that is being made in these fields. The major market effects of new therapeutics, with the potential of a breakthrough drug always a possibility, are expected to be seen over the next ten years. The technology trends selected in conjunction with the growing interest in psoriasis and its treatment present the most informative picture...
    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    Published: November 1, 2006 | Price: $1,500.00 – $5,990.00

    This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...
    Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)

    Published: November 1, 2007 | Price: $1,500.00 – $7,000.00

    Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in taking part in clinical trial research, and these regions can...
    World Alzheimer’s Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends), The

    Published: August 1, 2008 | Price: $1,500.00 – $4,995.00

    Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments. There is an opportunity for pharmaceutical companies to compete in this market, as Kalorama analyst Melissa Elder outlines in this study. This report includes incidence of Alzheimer’s disease worldwide with information...
    Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)

    Published: August 1, 2008 | Price: $1,500.00 – $7,000.00

    The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel to more important and productive tasks. For drug discovery, automation also offers benefits. bringing a new drug to market has been both a very time-intensive, laborious and expensive undertaking. This...
    Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century

    Published: August 1, 2008 | Price: $1,500.00 – $7,000.00

    Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...
    Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps)

    Published: September 1, 2008 | Price: $1,500.00 – $6,995.00

    Infusion pumps are used to infuse necessary fluids, which includes medications and/or nutrients, to a patient’s circulatory system. Infusion pumps are often used in situations where continuous monitoring and treatment by a nurse or other health staff would be expensive, impractical, or unreliable. For the purpose of this study, we have classified two general types of infusion pumps: General Purpose Infusion Pumps Specialty Infusion Pumps General purpose infusion pumps are used in a variety of applications and settings from basic...
    Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets)

    Published: February 1, 2009 | Price: $1,500.00 – $7,000.00

    The reinvigorated market for medical imaging systems employing x-rays has undoubtedly been propelled by the explosion of digital technology. But also, the expanded role of imaging modalities in a whole host of clinical applications from trauma to cancer to cardiology has increased the profile of radiography while enabling computer technologies expand the usefulness of traditional x-ray techniques. Kalorama's Medical Imaging Markets Volume I: Radiography analyzes the current and potential world market for medical x-ray systems, including several distinct imaging modalities...
    Who’s Doing What in Molecular Diagnostics ? – The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories

    Published: April 1, 2009 | Price: $1,500.00 – $9,990.00

    From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...
    Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition

    Published: May 1, 2009 | Price: $1,500.00 – $9,000.00

    Kalorama Information's 300 page Worldwide Wound Care: Total Market Coverage report represents the full contents of the Kalorama three-volume 2009 wound care series. The reports are joined in one volume to offer a better value to the customer that wants total market coverage. Kalorama's approach differs from other published reports in that we segment the world wound care market by application: skin ulcers, burns and surgical/trauma wounds. Wound care is a vast market and this approach ensures that customers can...